SELLAS Life Sciences SLS
NASDAQ SLS
$13.85 +0.15 (+1.13%)
As of: Sep 4, 2026 · 3:59 PM EDT

SELLAS Life Sciences (SLS) Goodwill & Intangibles (2011 - 2026)

SELLAS Life Sciences (SLS) posted quarterly Goodwill & Intangibles of $1.9 million for Q1 2026, little changed year-over-year from $1.9 million in Q1 2025, and little changed quarter-over-quarter from $1.9 million in Q4 2025.

Analysis

SELLAS Life Sciences (SLS) Goodwill & Intangibles (2011 - 2026) Analysis & Trends

SELLAS Life Sciences (SLS) has reported Goodwill & Intangibles for 16 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (changed 0.0% YoY), while the FY2025 annual figure was $1.9 million, changed 0.0% from the prior year.
  • Goodwill & Intangibles held at $1.9 million in Q1 2026 per SLS's latest filing, from $1.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $1.9 million in Q1 2022 and bottomed at $1.9 million in Q4 2023.
  • Historically, Goodwill & Intangibles has averaged $1.9 million across 5 years, with a median of $1.9 million in 2022.
  • Annual changes were most pronounced in 2022 — Goodwill & Intangibles advanced 0.74% — and 2023, when it dropped 0.73%.
  • SELLAS Life Sciences' Goodwill & Intangibles stood at $1.9 million in 2022, then fell by 0.73% to $1.9 million in 2023, then climbed by 0.74% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025, then changed by 0.0% to $1.9 million in 2026.
  • Business Quant data shows SLS's Goodwill & Intangibles at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 SELLAS Life Sciences 2.62 Bn 2.62 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.91 Mn
Mar 31, 2026 1.91 Mn
Dec 31, 2025 1.91 Mn
Sep 30, 2025 1.91 Mn
Jun 30, 2025 1.91 Mn
Mar 31, 2025 1.91 Mn
Dec 31, 2024 1.91 Mn
Sep 30, 2024 1.91 Mn
Jun 30, 2024 1.91 Mn
Mar 31, 2024 1.91 Mn
Dec 31, 2023 1.91 Mn
Sep 30, 2023 1.91 Mn
Jun 30, 2023 1.91 Mn
Mar 31, 2023 1.91 Mn
Dec 31, 2022 1.91 Mn
Sep 30, 2022 1.91 Mn
Jun 30, 2022 1.91 Mn
Mar 31, 2022 1.91 Mn
Dec 31, 2021 1.91 Mn
Sep 30, 2021 1.91 Mn